Vaccinontwikkeling bluetongue (WOT-01-003-051)

Project: EZproject

Project Details

StatusFinished
Effective start/end date1/04/1131/12/15

Research Output

Viral replication kinetics and in vitro cytopathogenicity of parental and reassortant strains of bluetongue virus serotype 1, 6 and 8

Coetzee, M. P. A., van Vuuren, M., Stokstad, M., Myrmel, M., van Gennip, H. G. P., van Rijn, P. A. & Venter, E. H., 2014, In : Veterinary Microbiology. 171, 1-2, p. 53-65

Research output: Contribution to journalArticleAcademicpeer-review

  • 12 Citations (Scopus)

    VP2-serotyped live-attenuated bluetongue virus without NS3/NS3a expression provided serotype-specific protection and enables DIVA.

    Feenstra, F., Maris-Veldhuis, M. A., Daus, F. J., Tacken, M. G. J., Moormann, R. J. M., van Gennip, H. G. P. & van Rijn, P. A., 2014, In : Vaccine. 32, 52, p. 7108-7114

    Research output: Contribution to journalArticleAcademicpeer-review

  • 19 Citations (Scopus)

    Bluetongue virus with mutated genome segment 10 to differentiate infected from vaccinated animals: A genetic DIVA approach

    van Rijn, P. A., van de Water, S. G. P. & van Gennip, H. G. P., 2013, In : Vaccine. 31, 44, p. 5005-5008

    Research output: Contribution to journalArticleAcademicpeer-review

  • 18 Citations (Scopus)